Becton Dickinson

/Becton Dickinson
­
23 12, 2014

Becton Dickinson-Aethon Collaboration to Enhance Medication Management

By |December 23rd, 2014|Becton Dickinson|Comments Off on Becton Dickinson-Aethon Collaboration to Enhance Medication Management

A medical technology company, Becton, Dickinson and Company (BDX) manufactures medical supplies, devices, laboratory equipment and diagnostic products. Becton Dickinson recently announced a tie-up with Aethon, Inc. aimed at enhancing medication management by pharmacies. According to a Nasdaq report, the companies will integrate their solutions to provide hospital pharmacies with a comprehensive intravenous medication preparation [...]

24 07, 2014

Cell Culture Market Could Be Worth $24,574 Million by 2018

By |July 24th, 2014|Becton Dickinson, Reagents|Comments Off on Cell Culture Market Could Be Worth $24,574 Million by 2018

New Markets and Markets research forecasts that the cell culture industry will grow at a CAGR of 10.71% during 2013-2018 and that it will be worth $24,574 million by 2018. The report features several application segments, namely, biopharmaceutical production, cancer research, drug screening and development, gene therapy, tissue culture and engineering, toxicity testing, vaccine production, [...]